Price $97.41 |
Market Cap
4.08B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
41.8
|
P/B
3.37
|
P/S
3.38
|
Dividend %
-
|
|
P/CF
585.7
|
P/FCF
58.8
|
Op. Cash Flow
110.9K
|
FCF
1.2
|
|
Op. Margin
9.80%
|
Net Margin
8.20%
|
ROE
8.40%
|
ROI
5.90%
|
|
ROA
5.70%
|
EPS Growth
60.20%
|
Current Ratio
2.4
|
Debt/Equity
16.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Omnicell Inc (OMCL) | $44.48 | - | - | 1.32B | Strong Buy |
| Evogene Ltd (EVGN) | $3.06 | - | - | 22.7M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
